Jim Stankovich
Overview
Explore the profile of Jim Stankovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haskell T, Stankovich J, Merridew N
Lancet Reg Health West Pac
. 2024 Jul;
48:101118.
PMID: 39036711
Bullying, discrimination, and harassment (BDH) within healthcare teams is a global issue that risks healthcare worker wellbeing, patient safety, public health, and industry reputations. Collectively, fragmented regulation, weak detection and...
2.
Jordan M, Gresle M, Gemiarto A, Stanley D, Smith L, Laverick L, et al.
Immunol Cell Biol
. 2024 Jun;
102(8):702-720.
PMID: 38877291
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system affecting predominantly adults. It is a complex disease associated with both environmental and genetic risk factors. Although over...
3.
Singh A, Akkala S, Nayak M, Kotlo A, Poondla N, Raza S, et al.
Geriatrics (Basel)
. 2024 May;
9(3.
PMID: 38804322
Pain, particularly musculoskeletal (MSK) and multi-site pain, significantly impacts activities of daily living (ADL) in the elderly, leading to a decline in overall quality of life (QoL). This study, comprising...
4.
Yeh W, Gresle M, Lea R, Taylor B, Lucas R, Ponsonby A, et al.
Clin Immunol
. 2024 Mar;
262:110183.
PMID: 38479439
Vitamin D deficiency is a risk factor for developing multiple sclerosis. The PrevANZ trial was conducted to determine if vitamin D supplementation can prevent recurrent disease activity in people with...
5.
Bridge F, Brotherton J, Stankovich J, Sanfilippo P, Skibina O, Buzzard K, et al.
Neurology
. 2024 Feb;
102(4):e208059.
PMID: 38306594
Background And Objectives: The impact of immunomodulatory therapies on the risk of cervical pre-cancer and invasive cancer development is important for the health and safety of women with multiple sclerosis...
6.
Yeh W, Lea R, Stankovich J, Sampangi S, Laverick L, van der Walt A, et al.
Sci Rep
. 2024 Jan;
14(1):1436.
PMID: 38228657
Vitamin D deficiency is a risk factor for developing multiple sclerosis (MS). However, the immune effects of vitamin D in people with MS are not well understood. We analyzed transcriptomic...
7.
Campagna M, Xavier A, Stankovich J, Maltby V, Slee M, Yeh W, et al.
Clin Epigenetics
. 2023 Feb;
15(1):20.
PMID: 36765422
Background: Pregnancy in women with multiple sclerosis (wwMS) is associated with a reduction of long-term disability progression. The mechanism that drives this effect is unknown, but converging evidence suggests a...
8.
Campagna M, Xavier A, Lea R, Stankovich J, Maltby V, Butzkueven H, et al.
Clin Epigenetics
. 2022 Dec;
14(1):194.
PMID: 36585691
Background: The variation in multiple sclerosis (MS) disease severity is incompletely explained by genetics, suggesting genetic and environmental interactions are involved. Moreover, the lack of prognostic biomarkers makes it difficult...
9.
Jokubaitis V, Campagna M, Ibrahim O, Stankovich J, Kleinova P, Matesanz F, et al.
Brain
. 2022 Nov;
146(6):2316-2331.
PMID: 36448302
Multiple sclerosis is a leading cause of neurological disability in adults. Heterogeneity in multiple sclerosis clinical presentation has posed a major challenge for identifying genetic variants associated with disease outcomes....
10.
Lin X, Yang Y, Gresle M, Cuellar-Partida G, Han X, Stankovich J, et al.
Brain
. 2022 Nov;
146(6):2464-2475.
PMID: 36346149
Understanding how variations in the plasma and brain proteome contribute to multiple sclerosis susceptibility can provide important insights to guide drug repurposing and therapeutic development for the disease. However, the...